P-cresol: Correlation With Glomerular Filtration Rate and Outcome in Chronic Kidney Disease
NCT00888030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2012-09-06
Summary
End-stage renal disease is a global epidemia with an estimated incidence of 7% per year and high morbidity-mortality rate. Early detection of chronic kidney disease (CKD) and intervention for CKD complication is important to retard renal progression. However, "traditional uremic toxin" or "small water-soluble molecules" are poorly correlated with the renal function, uremic symptoms and outcomes of CKD patients.
Putative protein-bound solute, p-cresol, is accumulated in ESRD patients receiving dialysis therapy. This uremic solute was associated with endothelial dysfunction, immune dysregulation and can predict outcome in hemodialysis patient. P-cresol inhibits endothelial cell proliferation and endothelial response to inflammatory cytokines. In vitro, p-cresol decreases leukocyte transendotherliar migratory function and inhibit production of phagocyte reactive species. Clinically, p-cresol plays a pathophysiological role in the uremic toxicity. High free serum level of p-cresol is associated with mortality in hemodialysis patients.
Information of p-cresol in CKD patients is not available. The investigators hypothesized p-cresol can be accumulated in early CKD and have a positive correlation with the morbidity- mortality of CKD patients.
Value of p-cresol in different stages of CRF is still unknown. Information of p-cresol in CKD patients is not available. The investigators hypothesized p-cresol can be accumulated in early CKD and have a positive correlation with the morbidity- mortality of CKD patients.
The principal aim of this prospective cohort study is to investigate the association between total serum levels of p-cresol and the glomerular filtration rate. The correlation of level of p-cresol and morbidity-mortality in CKD patients will be also evaluated.
To determine the relationship, patients of nephrology clinic with a diagnosis of CKD were enrolled in this prospective study and follow-up for 1-year period. The association between total and free serum levels of p-cresol and the glomerular filtration rate were evaluated in CKD patients. The p-cresol level was correlated with other many inflammatory markers (white blood cell counts, ferritin, hs-crp, leptin) and also with the hospitalization rate secondary to cardiovascular and infectious event. The renal outcome and all-cause mortality was assessed. Determination of this relationship can help to establish an accurate marker for early detection of CKD and also its prognostic role in CKD patients.
Conditions
- Risk Factors
- Renal Progression
- Death
Interventions
- OTHER
-
there are no interventions currently listed for this study
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
lead OTHER
Principal Investigators
-
Iwen Wu, MD · Chang Gung Memorial Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-05-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Dcr3 Levels in Blood and Urine on Renal and Patient Prognosis in Patients With Acute Kidney Injury
NCT05735093 ·Status: UNKNOWN
-
Comparison of Procalcitonin Level in Normal Population and in Chronic Kidney Disease Patients Who Don't Have Infection
NCT05585970 ·Status: UNKNOWN ·Phase: NA
-
Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease Patients
NCT00395005 ·Status: COMPLETED
-
A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients
NCT01236820 ·Status: UNKNOWN
-
Circulating lncRNA and CV Morbidities in CKD and ESRD
NCT02304471 ·Status: UNKNOWN
-
Soluble CD146 and Proteinuria in Chronic Renal Disease
NCT03341949 ·Status: COMPLETED ·Phase: NA
-
Risk of Chronic Kidney Disease Progression
NCT02654756 ·Status: COMPLETED
-
Population-based Chronic Kidney Disease Cohort at Northern Taiwan
NCT03004898 ·Status: UNKNOWN ·Phase: NA
-
Uremic Toxins and Outcomes in Chronic Kidney Disease
NCT03711617 ·Status: RECRUITING
-
The Effectiveness of Urine mtDNA and Beta 2-MG to Predict Acute Kidney Injury for Critically Ill Surgical Patients
NCT05458063 ·Status: COMPLETED
-
Serum Uromodulin and DN Systematic Review and Meta Analysis
NCT06596863 ·Status: COMPLETED
-
Quality Assessment Creatinines in Plasma and Urine
NCT01575392 ·Status: COMPLETED
-
Cohort Follow-up: Progression and Consequences of Chronic Kidney Disease.
NCT04070885 ·Status: COMPLETED
-
Uric Acid and Long-term Outcomes in Chronic Kidney Disease
NCT01158911 ·Status: COMPLETED
-
Recovery of Serum Creatinine at Discharge Impacts Mortality
NCT03417791 ·Status: UNKNOWN
-
How to Dose a Patient According to Renal Function? Glomerular Filtration Rate (GFR) or Creatinine Clearance (ClCr)
NCT02206373 ·Status: UNKNOWN
-
Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
NCT01588756 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chronic Kidney Disease : Role of Biological Factors and Apolipoprotein L1 Encoding Gene (APOL1)
NCT07288723 ·Status: COMPLETED
-
Determinants of Muscle Strength in Chronic Kidney Disease
NCT02806089 ·Status: COMPLETED ·Phase: NA
-
Contrast Medium Volume and Contrast-induced Nephropathy After Percutaneous Coronary Intervention
NCT01399203 ·Status: UNKNOWN
-
Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease Patients
NCT00651521 ·Status: UNKNOWN
-
Percutaneous Nephrolithotomy in Patients With Stage 2-4 Chronic Kidney Disease
NCT04943081 ·Status: UNKNOWN ·Phase: NA
-
Association Between Urine Concentration Ability and the Progression of Chronic Kidney Disease
NCT01423045 ·Status: UNKNOWN
-
Roles of Uremic Toxins in Uremic Sacropenia
NCT03060590 ·Status: COMPLETED
-
Prognosis of Acute Kidney Injury:China Collaborative Study on AKI(CCS-AKI)Study
NCT03061786 ·Status: WITHDRAWN